Wordt geladen...
Posaconazole Therapeutic Drug Monitoring in Pediatrics and Young Adults with Cancer
BACKGROUND: Limited information exists regarding the use of posaconazole for treating systemic fungal infections in children, adolescent, and young adult patients with cancer. At St. Jude Children’s Research Hospital, the recommended posaconazole dose in patients less than 34 kg is 18–24 mg/kg daily...
Bewaard in:
| Gepubliceerd in: | Ann Pharmacother |
|---|---|
| Hoofdauteurs: | , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2013
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4384822/ https://ncbi.nlm.nih.gov/pubmed/23737511 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1345/aph.1R775 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|